MarketCap
Facebook
X
Telegram
Helmerich & Payne Financial Ratios 2025-2006 | HP
Brief overview of Helmerich & Payne's market valuation
This overview follows the five latest available observations from 2015 through 2024.
The latest available valuation ratios are P/E 10.4x (median 13.97x), EV/EBITDA 3.95x (median 3.95x), P/S 0.71x (median 1.36x). Multiples are on average 25.5% below their own medians. Shares look cheaper than their recent historical valuation.
Earnings yield calculated as 1/P/E is about 9.6%, showing current profit per unit of share price.
End-period return metrics are ROE -5.8%, ROA -2.4%, ROCE 0.1%. Current return ratios are negative, materially weakening the fundamental profile.
The cash return period is stable at 74.8 days initially and 65 days at the end.
Overall assessment
Helmerich & Payne trades below its own history, but weak profitability may explain the discount. Low multiples alone do not prove undervaluation.
Annual Financial Ratios Helmerich & Payne
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-16.3 | 10.4 | 9.0 | 581.6 | -7.7 | -3.2 | -123.6 | 14.0 | -45.5 | -120.6 | 14.4 | 12.9 | 11.2 | 8.8 | 14.0 | 36.4 | 11.0 | 14.3 | 7.8 | - |
P/S |
0.7 | 1.3 | 1.4 | 2.0 | 2.1 | 0.9 | 1.5 | 2.7 | 3.2 | 4.2 | 1.9 | 2.5 | 2.4 | 1.6 | 2.4 | - | - | - | - | - |
EPS |
-1.7 | 3.4 | 4.2 | 0.1 | -3.0 | -4.6 | -0.3 | 4.4 | -1.2 | -0.5 | 3.9 | 6.5 | 6.9 | 5.4 | 4.1 | 1.0 | 0.6 | 4.4 | 4.3 | - |
EV (Enterprise Value) |
2.48 B | 3.36 B | 3.66 B | 3.81 B | 1.59 B | 2.63 B | 5.64 B | 8.29 B | 7.59 B | 8.22 B | 7.59 B | 10.6 B | 9.61 B | 6.93 B | 7.44 B | 3.73 B | 3.78 B | 6.54 B | 3.43 B | -33.9 M |
EBITDA per Share |
6.33 | 8.65 | 9.28 | 4.24 | -0.08 | 3.65 | 7.03 | 5.66 | 3.62 | 5.27 | 12.2 | 14.5 | 13.1 | 12 | 9.55 | 4.1 | 3.16 | 8.01 | 7.53 | - |
EV/EBITDA |
3.9 | 3.9 | 3.8 | 8.5 | -177.1 | 4.1 | 5.6 | 11.3 | 14.8 | 11.3 | 4.5 | 5.7 | 5.7 | 4.1 | 5.9 | 8.6 | 11.4 | 7.8 | 4.4 | - |
PEG |
0.02 | -0.01 | -0.01 | -0.53 | 0.38 | -0.0 | 1.15 | -0.03 | -0.37 | 1.06 | -0.36 | -2.54 | 0.41 | 0.26 | 0.08 | - | - | - | - | - |
P/B |
0.4 | 0.6 | 0.9 | 0.9 | 0.5 | 0.5 | 1.0 | 1.5 | 1.4 | 1.5 | 1.2 | 1.9 | 1.9 | 1.3 | 1.9 | 0.9 | 0.9 | 1.8 | - | - |
P/CF |
4.9 | 5.2 | 4.7 | 17.3 | 18.4 | 4.0 | 10.5 | 86.5 | -144.7 | 13.8 | 21.3 | 55.2 | 43.8 | -52.8 | 21.4 | 8.2 | 4.3 | 11.2 | 6.2 | - |
ROE % |
-5.79 | 11.80 | 15.66 | 0.25 | -11.20 | -14.90 | -0.84 | 11.01 | -3.08 | -1.25 | 8.62 | 14.49 | 16.58 | 15.15 | 13.28 | 3.71 | 13.18 | 20.38 | 24.75 | - |
ROA % |
-2.44 | 5.95 | 9.91 | 0.16 | -6.48 | -10.24 | -0.58 | 7.77 | -1.99 | -0.83 | 5.90 | 10.54 | 11.76 | 10.16 | 8.68 | 2.44 | 8.50 | 12.87 | - | - |
ROCE % |
0.06 | 8.57 | 14.34 | 1.14 | -10.28 | -1.90 | 3.78 | 0.55 | -3.17 | -0.46 | 10.34 | 16.66 | 16.13 | 16.67 | 15.31 | 4.23 | 2.73 | 19.52 | 34.83 | - |
Current Ratio |
- | - | - | - | - | 4.4 | 2.7 | 3.0 | 3.6 | 4.8 | 4.1 | 2.5 | 2.8 | 2.3 | 2.3 | - | - | - | - | - |
DSO |
58.5 | 54.5 | 54.8 | 58.8 | 59.5 | 40.1 | 64.9 | 82.9 | 96.5 | 84.3 | 51.8 | 69.2 | 67.0 | 71.9 | 66.1 | - | - | - | - | - |
DIO |
32.1 | 23.8 | 19.5 | 22.0 | 36.1 | 22.7 | 23.0 | 25.8 | 27.3 | 30.3 | 20.3 | 15.3 | 14.1 | 16.4 | 13.9 | - | - | - | - | - |
DPO |
25.7 | 29.9 | 27.5 | 25.5 | 20.8 | 8.0 | 19.0 | 21.7 | 27.0 | 23.3 | 17.5 | 26.2 | 22.8 | 33.2 | 26.5 | - | - | - | - | - |
Operating Cycle |
90.7 | 78.3 | 74.3 | 80.8 | 95.5 | 62.9 | 88.0 | 108.8 | 123.8 | 114.6 | 72.1 | 84.5 | 81.0 | 88.3 | 79.9 | - | - | - | - | - |
Cash Conversion Cycle |
65.0 | 48.4 | 46.8 | 55.3 | 74.8 | 54.9 | 69.0 | 87.1 | 96.8 | 91.4 | 54.7 | 58.3 | 58.2 | 55.0 | 53.5 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Helmerich & Payne
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.74 | -0.59 | -0.98 | -0.98 | - | 0.01 | 0.01 | 0.55 | - | 0.89 | 0.85 | 0.95 | - | 0.93 | 1.55 | 0.92 | - | 0.16 | -0.05 | -0.48 | - | -0.52 | -1.13 | -0.66 | -0.55 | -0.43 | -0.66 | 0.27 | 0.37 | -1.42 | 0.27 | 0.17 | 0.02 | -0.08 | 0.17 | 4.57 | -0.21 | -0.21 | 4.57 | -0.33 | -0.68 | -0.2 | -0.33 | 0.15 | -0.26 | 0.84 | 0.15 | 1.87 | 1.55 | 1.77 | 1.87 | 1.61 | 1.49 | 2.49 | 1.61 | 1.5 | 1.48 | 1.4 | 1.5 | 1.34 | 1.13 | 1.02 | 1.34 | -0.35 | 0.44 | 0.6 | 0.5 |
EBITDA per Share |
3.69 | 1.44 | 1.23 | 1.23 | - | 2.01 | 2.01 | 1.92 | - | 2.12 | 2.18 | 2.19 | - | 2.41 | 2.61 | 2.29 | - | 1.28 | 0.76 | 0.54 | - | 0.25 | -0.51 | 0.13 | 2.74 | 0.49 | 0.13 | 1.49 | 4.27 | -0.22 | 1.49 | 1.79 | 4.21 | 1.39 | 1.79 | 1.35 | 3.71 | 1.08 | 1.35 | 0.78 | 3.05 | 1.16 | 0.78 | 1.68 | 3.79 | 2.6 | 1.68 | 4.34 | 5.91 | 3.71 | 4.35 | 3.59 | 5.46 | 3.36 | 3.59 | 3.28 | 4.77 | 3.06 | 3.28 | 2.96 | 3.96 | 2.37 | 2.96 | 1.67 | 1.37 | 1.56 | 1.45 |
ROE % |
-6.55 | -9.33 | -7.05 | -1.61 | 1.97 | 5.07 | 8.04 | 11.44 | 9.58 | 13.10 | 15.95 | 16.46 | 13.01 | 13.66 | 9.96 | 2.16 | -1.38 | -3.23 | -5.73 | -7.73 | -5.88 | -8.06 | -8.40 | -8.74 | -5.78 | -2.83 | 0.13 | 3.08 | 2.75 | 2.03 | 1.70 | 1.37 | 11.83 | 11.23 | 10.27 | 20.72 | 9.05 | 7.99 | 8.05 | -3.61 | -2.50 | -1.47 | 0.85 | 1.95 | 5.76 | 9.77 | 11.84 | 15.67 | 15.32 | 15.47 | 17.53 | 17.27 | 17.48 | 17.98 | 15.90 | 16.17 | 16.36 | 15.97 | 15.42 | 15.67 | 10.13 | 8.09 | 7.02 | 4.65 | 1.67 | 2.29 | 2.04 |
ROA % |
-2.72 | -3.90 | -2.95 | -0.51 | 0.99 | 2.96 | 4.86 | 6.99 | 6.05 | 8.24 | 10.02 | 10.31 | 8.15 | 8.04 | 4.68 | -0.32 | -2.52 | -2.52 | -3.54 | -4.92 | -3.75 | -5.20 | -5.43 | -5.86 | -3.85 | -1.87 | 0.11 | 2.10 | 1.88 | 1.40 | 1.18 | 0.96 | 8.51 | 8.12 | 7.48 | 14.94 | 6.55 | 5.84 | 5.86 | -2.41 | -1.67 | -0.99 | 0.60 | 1.33 | 4.10 | 7.00 | 8.59 | 11.38 | 11.09 | 11.13 | 12.52 | 12.27 | 12.25 | 12.45 | 10.82 | 10.85 | 10.90 | 10.58 | 10.16 | 10.25 | 6.60 | 5.29 | 4.59 | 3.00 | 1.11 | 1.49 | 1.30 |
ROCE % |
0.67 | -2.10 | -0.76 | 1.97 | 3.02 | 5.78 | 7.90 | 10.37 | 8.68 | 12.48 | 14.15 | 15.02 | 11.90 | 13.13 | 8.75 | 3.25 | -0.40 | -2.23 | -7.46 | -8.96 | -7.89 | -9.56 | -9.01 | -7.08 | -4.43 | -2.04 | -3.87 | -1.23 | -0.86 | -1.17 | 2.05 | 2.41 | 1.52 | 0.62 | 0.05 | -0.83 | -1.66 | -2.61 | -2.35 | -3.16 | -1.82 | -0.75 | 1.44 | 2.77 | 7.39 | 11.99 | 14.38 | 19.16 | 18.41 | 18.35 | 18.10 | 17.31 | 17.22 | 17.52 | 17.75 | 17.71 | 18.12 | 17.85 | 17.29 | 17.81 | 15.92 | 13.69 | 12.50 | 9.94 | 1.98 | 2.62 | 2.46 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.2 | 3.2 | 3.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
74.1 | 75.2 | 65.2 | 67.7 | - | 70.6 | 54.5 | 57.0 | - | 55.4 | 57.5 | 56.6 | - | 61.5 | 61.6 | 61.6 | - | 27.3 | 59.7 | 56.9 | - | 63.5 | 71.2 | 78.9 | 84.4 | 104.1 | 191.2 | 74.0 | 69.7 | 65.7 | 77.3 | 68.4 | 74.0 | 79.5 | 86.9 | 81.9 | 81.8 | 87.3 | 65.0 | 86.9 | 103.2 | 37.0 | 92.7 | 76.7 | 73.5 | 61.5 | 110.4 | 61.9 | 65.3 | 67.6 | 57.7 | 64.2 | 65.6 | 67.5 | 61.7 | 64.9 | 68.3 | 69.1 | 60.3 | 59.5 | 60.0 | 65.2 | 49.5 | - | - | - | - |
DIO |
43.7 | 45.2 | 43.4 | 43.4 | - | 41.8 | 29.2 | 27.2 | - | 24.4 | 23.7 | 22.1 | - | 21.3 | 19.3 | 19.0 | - | 10.1 | 22.9 | 26.1 | - | 31.2 | 36.3 | 46.7 | 9.3 | 46.3 | 58.1 | 34.1 | 9.9 | 30.8 | 36.3 | 29.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
25.6 | 25.2 | 25.2 | 27.1 | - | 35.5 | 27.4 | 31.5 | - | 34.7 | 35.9 | 32.6 | - | 33.1 | 31.1 | 29.1 | - | 12.8 | 28.8 | 27.6 | - | 24.3 | 23.5 | 19.1 | 3.3 | 16.2 | 36.5 | 19.2 | 5.6 | 25.4 | 31.0 | 25.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 111.1 | - | - | 83.7 | 84.2 | - | 79.7 | 81.2 | 78.7 | - | 82.8 | 80.9 | 80.6 | - | 37.5 | 82.7 | 83.0 | - | 94.7 | 107.6 | 125.7 | 93.7 | 150.4 | 249.3 | 108.1 | 79.6 | 96.5 | 113.6 | 98.2 | 74.0 | 79.5 | 86.9 | 81.9 | 81.8 | 87.3 | 65.0 | 86.9 | 103.2 | 37.0 | 92.7 | 76.7 | 73.5 | 61.5 | 110.4 | 61.9 | 65.3 | 67.6 | 57.7 | 64.2 | 65.6 | 67.5 | 61.7 | 64.9 | 68.3 | 69.1 | 60.3 | 59.5 | 60.0 | 65.2 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 84.0 | - | - | 56.3 | 52.7 | - | 45.0 | 45.4 | 46.1 | - | 49.7 | 49.8 | 51.6 | - | 24.7 | 53.9 | 55.5 | - | 70.4 | 84.1 | 106.6 | 90.4 | 134.2 | 212.7 | 88.9 | 74.0 | 71.2 | 82.6 | 72.6 | 74.0 | 79.5 | 86.9 | 81.9 | 81.8 | 87.3 | 65.0 | 86.9 | 103.2 | 37.0 | 92.7 | 76.7 | 73.5 | 61.5 | 110.4 | 61.9 | 65.3 | 67.6 | 57.7 | 64.2 | 65.6 | 67.5 | 61.7 | 64.9 | 68.3 | 69.1 | 60.3 | 59.5 | 60.0 | 65.2 | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Helmerich & Payne, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Canada
Russia
Bermuda
China
Indonesia
